Castile Resources Ltd

CST

Castile Resources Ltd. owns and operates gold and copper projects. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-14. The Company’s projects include the Rover Project, Warumpi Project and Milgun Project. The Rover Project is located 80 kilometers (Km) southwest of the township of Tennant Creek in the Northern Territory. The total tenement area is approximately 1,054 square kilometers (km2) covering a proportion of the Rover Mineral Field. The Rover Project area is covered entirely by recent sediments which blanket flat-lying Cambrian siltstone, dolomitic siltstone, and sandstone units of the Wiso Basin. The Warumpi Project is located approximately 300 km west of Alice Springs and approximately 500 km southwest of the Rover Project. The Milgun Project is located approximately 150km north-northwest of Meekatharra in the Peak Hill Mineral Field of Western Australia and comprises tenements E52/4206 and E52/4235.

Cleanspace Holdings Limited

CSX

CleanSpace Holdings Ltd. designs, manufactures and sells workplace respiratory protection equipment for healthcare and industrial end markets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2020-10-23. The firm provides respiratory protection equipment for healthcare and industrial applications. The Company’s product offerings include CleanSpace HALO, CleanSpace2, CleanSpace ULTRA and CleanSpace EX. The firm provides a clinically designed powered air purifying respirator (PAPR) system, CleanSpace Halo, which is compatible with other personal protective equipment (PPE) and clinical head gear. CleanSpace2 is suitable for industries such as metal fabrication and welding; chemical or biological material handling; maintenance and cleaning; grain and food handling; high dust environments; mining and quarry; and stone, cement and concrete handling. Its subsidiaries include CleanSpace IP Pty Ltd, CleanSpace Technology Pty Limited, CleanSpace Americas, Inc, CleanSpace Technology Singapore Pte Ltd and CleanSpace NZ Ltd.

Capstone Copper Corp.

CSC

Capstone Copper Corp. operates as a copper producer with a diversified portfolio of operating assets focused in the Americas with an extensive pipeline of near term organic growth opportunities. The company is headquartered in Vancouver, British Columbia and currently employs 3,323 full-time employees. The company is engaged in the production of and exploration of base metals in the United States (US), Mexico, and Chile, with a focus on copper. The Company, through a wholly owned Chilean subsidiary, Mantos Copper S.A., owns and operates the Mantos Blancos mine, located 45 kilometers (km) northeast of Antofagasta, Chile and the 70%-owned Mantoverde mine, through a subsidiary, Mantoverde S.A., located 50 km southeast of Chanaral, Chile. The company owns and operates the Pinto Valley mine located in Arizona, US, Cozamin mine located in Zacatecas, Mexico, and has a portfolio of exploration properties in Mexico. The company also holds the fully permitted Santo Domingo copper-iron-gold-cobalt development project in the Atacama region of Chile, 35km northeast of Mantoverde. Through Compania Minera Sierra Norte S.A., it owns 100% of Sierra Norte, an iron oxide copper gold deposit located in Chile's Atacama Region, that spans over 7,000 hectares.

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.